0001209191-18-045090.txt : 20180802
0001209191-18-045090.hdr.sgml : 20180802
20180802185014
ACCESSION NUMBER: 0001209191-18-045090
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180802
FILED AS OF DATE: 20180802
DATE AS OF CHANGE: 20180802
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Witz Pascale
CENTRAL INDEX KEY: 0001703723
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35238
FILM NUMBER: 18989932
MAIL ADDRESS:
STREET 1: C/O REGULUS THERAPEUTICS INC.
STREET 2: 10614 SCIENCE CENTER DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Horizon Pharma plc
CENTRAL INDEX KEY: 0001492426
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 272179987
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CONNAUGHT HOUSE, 1ST FLOOR
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
BUSINESS PHONE: 011-353-1-772-2100
MAIL ADDRESS:
STREET 1: CONNAUGHT HOUSE, 1ST FLOOR
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
FORMER COMPANY:
FORMER CONFORMED NAME: HORIZON PHARMA, INC.
DATE OF NAME CHANGE: 20100520
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-08-02
0
0001492426
Horizon Pharma plc
HZNP
0001703723
Witz Pascale
C/O HORIZON PHARMA PLC
CONNAUGHT HOUSE, 1ST FL, 1 BURLINGTON RD
DUBLIN
L2
4
IRELAND
1
0
0
0
Ordinary Shares
2018-08-02
4
M
0
8203
A
8203
I
By Trust
Ordinary Shares
2018-08-02
4
F
0
2213
18.18
D
5990
I
By Trust
Restricted Stock Units
2018-08-02
4
M
0
8203
0.00
D
Ordinary shares
8203
16407
D
Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
The shares subject to the restricted stock units vest in three equal annual installments on the anniversary of the grant date (August 2, 2017).
/s/ Miles W. McHugh, Attorney-in-Fact
2018-08-02